Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global SARS-CoV-2 IgG(RBD) ELISA Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 ELISA Sets
1.2.3 ELISA Kits
1.3 Market by Application
1.3.1 Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Disease control and prevention system
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global SARS-CoV-2 IgG(RBD) ELISA Market Perspective (2016-2027)
2.2 SARS-CoV-2 IgG(RBD) ELISA Growth Trends by Regions
2.2.1 SARS-CoV-2 IgG(RBD) ELISA Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 SARS-CoV-2 IgG(RBD) ELISA Historic Market Share by Regions (2016-2021)
2.2.3 SARS-CoV-2 IgG(RBD) ELISA Forecasted Market Size by Regions (2022-2027)
2.3 SARS-CoV-2 IgG(RBD) ELISA Industry Dynamic
2.3.1 SARS-CoV-2 IgG(RBD) ELISA Market Trends
2.3.2 SARS-CoV-2 IgG(RBD) ELISA Market Drivers
2.3.3 SARS-CoV-2 IgG(RBD) ELISA Market Challenges
2.3.4 SARS-CoV-2 IgG(RBD) ELISA Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top SARS-CoV-2 IgG(RBD) ELISA Players by Revenue
3.1.1 Global Top SARS-CoV-2 IgG(RBD) ELISA Players by Revenue (2016-2021)
3.1.2 Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share by Players (2016-2021)
3.2 Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by SARS-CoV-2 IgG(RBD) ELISA Revenue
3.4 Global SARS-CoV-2 IgG(RBD) ELISA Market Concentration Ratio
3.4.1 Global SARS-CoV-2 IgG(RBD) ELISA Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by SARS-CoV-2 IgG(RBD) ELISA Revenue in 2020
3.5 SARS-CoV-2 IgG(RBD) ELISA Key Players Head office and Area Served
3.6 Key Players SARS-CoV-2 IgG(RBD) ELISA Product Solution and Service
3.7 Date of Enter into SARS-CoV-2 IgG(RBD) ELISA Market
3.8 Mergers & Acquisitions, Expansion Plans

4 SARS-CoV-2 IgG(RBD) ELISA Breakdown Data by Type
4.1 Global SARS-CoV-2 IgG(RBD) ELISA Historic Market Size by Type (2016-2021)
4.2 Global SARS-CoV-2 IgG(RBD) ELISA Forecasted Market Size by Type (2022-2027)

5 SARS-CoV-2 IgG(RBD) ELISA Breakdown Data by Application
5.1 Global SARS-CoV-2 IgG(RBD) ELISA Historic Market Size by Application (2016-2021)
5.2 Global SARS-CoV-2 IgG(RBD) ELISA Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America SARS-CoV-2 IgG(RBD) ELISA Market Size (2016-2027)
6.2 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type
6.2.1 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021)
6.2.2 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027)
6.2.3 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2027)
6.3 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application
6.3.1 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021)
6.3.2 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027)
6.3.3 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2027)
6.4 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country
6.4.1 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021)
6.4.2 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size (2016-2027)
7.2 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Type
7.2.1 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021)
7.2.2 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027)
7.2.3 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2027)
7.3 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Application
7.3.1 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021)
7.3.2 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027)
7.3.3 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2027)
7.4 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Country
7.4.1 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021)
7.4.2 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size (2016-2027)
8.2 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Type
8.2.1 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021)
8.2.2 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027)
8.2.3 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2027)
8.3 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Application
8.3.1 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021)
8.3.2 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027)
8.3.3 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2027)
8.4 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Region
8.4.1 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Region (2016-2021)
8.4.2 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size (2016-2027)
9.2 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type
9.2.1 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021)
9.2.2 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027)
9.2.3 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2027)
9.3 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application
9.3.1 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021)
9.3.2 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027)
9.3.3 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2027)
9.4 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country
9.4.1 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021)
9.4.2 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size (2016-2027)
10.2 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Type
10.2.1 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021)
10.2.2 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027)
10.2.3 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2027)
10.3 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Application
10.3.1 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021)
10.3.2 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027)
10.3.3 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2027)
10.4 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Country
10.4.1 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021)
10.4.2 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 R&D Systems
11.1.1 R&D Systems Company Details
11.1.2 R&D Systems Business Overview
11.1.3 R&D Systems SARS-CoV-2 IgG(RBD) ELISA Introduction
11.1.4 R&D Systems Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.1.5 R&D Systems Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific SARS-CoV-2 IgG(RBD) ELISA Introduction
11.2.4 Thermo Fisher Scientific Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Ortho Clinical Diagnostics
11.3.1 Ortho Clinical Diagnostics Company Details
11.3.2 Ortho Clinical Diagnostics Business Overview
11.3.3 Ortho Clinical Diagnostics SARS-CoV-2 IgG(RBD) ELISA Introduction
11.3.4 Ortho Clinical Diagnostics Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.3.5 Ortho Clinical Diagnostics Recent Development
11.4 BD Biosciences
11.4.1 BD Biosciences Company Details
11.4.2 BD Biosciences Business Overview
11.4.3 BD Biosciences SARS-CoV-2 IgG(RBD) ELISA Introduction
11.4.4 BD Biosciences Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.4.5 BD Biosciences Recent Development
11.5 ZEUS Scientific
11.5.1 ZEUS Scientific Company Details
11.5.2 ZEUS Scientific Business Overview
11.5.3 ZEUS Scientific SARS-CoV-2 IgG(RBD) ELISA Introduction
11.5.4 ZEUS Scientific Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.5.5 ZEUS Scientific Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories SARS-CoV-2 IgG(RBD) ELISA Introduction
11.6.4 Bio-Rad Laboratories Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 ALPCO
11.7.1 ALPCO Company Details
11.7.2 ALPCO Business Overview
11.7.3 ALPCO SARS-CoV-2 IgG(RBD) ELISA Introduction
11.7.4 ALPCO Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.7.5 ALPCO Recent Development
11.8 Enzo Life Sciences
11.8.1 Enzo Life Sciences Company Details
11.8.2 Enzo Life Sciences Business Overview
11.8.3 Enzo Life Sciences SARS-CoV-2 IgG(RBD) ELISA Introduction
11.8.4 Enzo Life Sciences Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.8.5 Enzo Life Sciences Recent Development
11.9 BioMérieux
11.9.1 BioMérieux Company Details
11.9.2 BioMérieux Business Overview
11.9.3 BioMérieux SARS-CoV-2 IgG(RBD) ELISA Introduction
11.9.4 BioMérieux Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.9.5 BioMérieux Recent Development
11.10 LOEWE Biochemica
11.10.1 LOEWE Biochemica Company Details
11.10.2 LOEWE Biochemica Business Overview
11.10.3 LOEWE Biochemica SARS-CoV-2 IgG(RBD) ELISA Introduction
11.10.4 LOEWE Biochemica Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.10.5 LOEWE Biochemica Recent Development
11.11 Shenzhen YHLO Biotech
11.11.1 Shenzhen YHLO Biotech Company Details
11.11.2 Shenzhen YHLO Biotech Business Overview
11.11.3 Shenzhen YHLO Biotech SARS-CoV-2 IgG(RBD) ELISA Introduction
11.11.4 Shenzhen YHLO Biotech Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.11.5 Shenzhen YHLO Biotech Recent Development
11.12 LG
11.12.1 LG Company Details
11.12.2 LG Business Overview
11.12.3 LG SARS-CoV-2 IgG(RBD) ELISA Introduction
11.12.4 LG Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.12.5 LG Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global SARS-CoV-2 IgG(RBD) ELISA Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of ELISA Sets
Table 3. Key Players of ELISA Kits
Table 4. Global SARS-CoV-2 IgG(RBD) ELISA Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global SARS-CoV-2 IgG(RBD) ELISA Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global SARS-CoV-2 IgG(RBD) ELISA Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Regions (2016-2021)
Table 8. Global SARS-CoV-2 IgG(RBD) ELISA Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Regions (2022-2027)
Table 10. SARS-CoV-2 IgG(RBD) ELISA Market Trends
Table 11. SARS-CoV-2 IgG(RBD) ELISA Market Drivers
Table 12. SARS-CoV-2 IgG(RBD) ELISA Market Challenges
Table 13. SARS-CoV-2 IgG(RBD) ELISA Market Restraints
Table 14. Global SARS-CoV-2 IgG(RBD) ELISA Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Players (2016-2021)
Table 16. Global Top SARS-CoV-2 IgG(RBD) ELISA Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in SARS-CoV-2 IgG(RBD) ELISA as of 2020)
Table 17. Ranking of Global Top SARS-CoV-2 IgG(RBD) ELISA Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by SARS-CoV-2 IgG(RBD) ELISA Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players SARS-CoV-2 IgG(RBD) ELISA Product Solution and Service
Table 21. Date of Enter into SARS-CoV-2 IgG(RBD) ELISA Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021) (US$ Million)
Table 24. Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share by Type (2016-2021)
Table 25. Global SARS-CoV-2 IgG(RBD) ELISA Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global SARS-CoV-2 IgG(RBD) ELISA Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share by Application (2016-2021)
Table 29. Global SARS-CoV-2 IgG(RBD) ELISA Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021) (US$ Million)
Table 32. North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021) (US$ Million)
Table 34. North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027) & (US$ Million)
Table 61. R&D Systems Company Details
Table 62. R&D Systems Business Overview
Table 63. R&D Systems SARS-CoV-2 IgG(RBD) ELISA Product
Table 64. R&D Systems Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 65. R&D Systems Recent Development
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific SARS-CoV-2 IgG(RBD) ELISA Product
Table 69. Thermo Fisher Scientific Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 70. Thermo Fisher Scientific Recent Development
Table 71. Ortho Clinical Diagnostics Company Details
Table 72. Ortho Clinical Diagnostics Business Overview
Table 73. Ortho Clinical Diagnostics SARS-CoV-2 IgG(RBD) ELISA Product
Table 74. Ortho Clinical Diagnostics Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 75. Ortho Clinical Diagnostics Recent Development
Table 76. BD Biosciences Company Details
Table 77. BD Biosciences Business Overview
Table 78. BD Biosciences SARS-CoV-2 IgG(RBD) ELISA Product
Table 79. BD Biosciences Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 80. BD Biosciences Recent Development
Table 81. ZEUS Scientific Company Details
Table 82. ZEUS Scientific Business Overview
Table 83. ZEUS Scientific SARS-CoV-2 IgG(RBD) ELISA Product
Table 84. ZEUS Scientific Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 85. ZEUS Scientific Recent Development
Table 86. Bio-Rad Laboratories Company Details
Table 87. Bio-Rad Laboratories Business Overview
Table 88. Bio-Rad Laboratories SARS-CoV-2 IgG(RBD) ELISA Product
Table 89. Bio-Rad Laboratories Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 90. Bio-Rad Laboratories Recent Development
Table 91. ALPCO Company Details
Table 92. ALPCO Business Overview
Table 93. ALPCO SARS-CoV-2 IgG(RBD) ELISA Product
Table 94. ALPCO Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 95. ALPCO Recent Development
Table 96. Enzo Life Sciences Company Details
Table 97. Enzo Life Sciences Business Overview
Table 98. Enzo Life Sciences Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 99. Enzo Life Sciences Recent Development
Table 100. BioMérieux Company Details
Table 101. BioMérieux Business Overview
Table 102. BioMérieux SARS-CoV-2 IgG(RBD) ELISA Product
Table 103. BioMérieux Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 104. BioMérieux Recent Development
Table 105. LOEWE Biochemica Company Details
Table 106. LOEWE Biochemica Business Overview
Table 107. LOEWE Biochemica SARS-CoV-2 IgG(RBD) ELISA Product
Table 108. LOEWE Biochemica Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 109. LOEWE Biochemica Recent Development
Table 110. Shenzhen YHLO Biotech Company Details
Table 111. Shenzhen YHLO Biotech Business Overview
Table 112. Shenzhen YHLO Biotech SARS-CoV-2 IgG(RBD) ELISA Product
Table 113. Shenzhen YHLO Biotech Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 114. Shenzhen YHLO Biotech Recent Development
Table 115. LG Company Details
Table 116. LG Business Overview
Table 117. LG SARS-CoV-2 IgG(RBD) ELISA Product
Table 118. LG Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 119. LG Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Type: 2020 VS 2027
Figure 2. ELISA Sets Features
Figure 3. ELISA Kits Features
Figure 4. Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Disease control and prevention system Case Studies
Figure 8. SARS-CoV-2 IgG(RBD) ELISA Report Years Considered
Figure 9. Global SARS-CoV-2 IgG(RBD) ELISA Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global SARS-CoV-2 IgG(RBD) ELISA Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Regions: 2020 VS 2027
Figure 12. Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Regions (2022-2027)
Figure 13. Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Players in 2020
Figure 14. Global Top SARS-CoV-2 IgG(RBD) ELISA Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in SARS-CoV-2 IgG(RBD) ELISA as of 2020
Figure 15. The Top 10 and 5 Players Market Share by SARS-CoV-2 IgG(RBD) ELISA Revenue in 2020
Figure 16. Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share by Type (2016-2021)
Figure 17. Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share by Type (2022-2027)
Figure 18. North America SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America SARS-CoV-2 IgG(RBD) ELISA Market Share by Type (2016-2027)
Figure 20. North America SARS-CoV-2 IgG(RBD) ELISA Market Share by Application (2016-2027)
Figure 21. North America SARS-CoV-2 IgG(RBD) ELISA Market Share by Country (2016-2027)
Figure 22. United States SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe SARS-CoV-2 IgG(RBD) ELISA Market Share by Type (2016-2027)
Figure 26. Europe SARS-CoV-2 IgG(RBD) ELISA Market Share by Application (2016-2027)
Figure 27. Europe SARS-CoV-2 IgG(RBD) ELISA Market Share by Country (2016-2027)
Figure 28. Germany SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Share by Type (2016-2027)
Figure 36. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Share by Application (2016-2027)
Figure 37. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Share by Region (2016-2027)
Figure 38. China SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Share by Type (2016-2027)
Figure 46. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Share by Application (2016-2027)
Figure 47. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Share by Country (2016-2027)
Figure 48. Mexico SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Share by Type (2016-2027)
Figure 52. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Share by Application (2016-2027)
Figure 53. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Share by Country (2016-2027)
Figure 54. Turkey SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. R&D Systems Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 59. Ortho Clinical Diagnostics Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 60. BD Biosciences Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 61. ZEUS Scientific Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 62. Bio-Rad Laboratories Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 63. ALPCO Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 64. Enzo Life Sciences Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 65. BioMérieux Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 66. LOEWE Biochemica Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 67. Shenzhen YHLO Biotech Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 68. LG Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed